GeorgeKurdgelashviliMD(He/Him)
Internal Medicine • Oklahoma City, OKHospital Medicine/Hospitalist, Infectious Disease
Chief of Medicine Oklahoma City VA Healthcare System Clinical Professor, Dept of Medicine, University of Oklahoma College of Medicine
Dr. Kurdgelashvili is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
921 NE 13th street 111 C
Oklahoma City, OK 73104Phone+1 405-456-1000- Is this information wrong?
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Infectious Disease, 2002 - 2004
Emory University School of MedicineResidency, Internal Medicine, 1999 - 2002
Tbilisi State Medical UniversityClass of 1996
Certifications & Licensure
OK State Medical License 2002 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- VA CoronavirUs Research and Efficacy Studies-1 Start of enrollment: 2020 Nov 16
- Optimal Treatment for Recurrent Clostridium Difficile Start of enrollment: 2015 Dec 21
Roles: Contact
- Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics Start of enrollment: 2018 Jan 22
Roles: Contact
Publications & Presentations
PubMed
- 2 citationsCharacteristics and Outcomes of US Veterans With Immunocompromised Conditions at High Risk of SARS-CoV-2 Infection With or Without Receipt of Oral Antiviral Agents.Chris A Gentry, Phoi N Nguyen, Sharanjeet K Thind, George Kurdgelashvili, Riley J Williams 2nd> ;Clinical Infectious Diseases. 2024 Feb 17
- 11 citationsCharacteristics and outcomes of US Veterans at least 65 years of age at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents.Chris A Gentry, Phoi Nguyen, Sharanjeet K Thind, George Kurdgelashvili, Riley J Williams> ;The Journal of Infection. 2023 Mar 1
- Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine monotherapy vs. patients without rheumatic conditions: A retrospective,...Chris A Gentry, Sharanjeet K Thind, Riley J Williams 2nd, Sage C Hendrickson, George Kurdgelashvili, Mary Beth Humphrey> ;The American Journal of the Medical Sciences. 2023 Jan 1
- Join now to see all
Press Mentions
HPV-related cancers rose before vaccines hit marketApril 27th, 2022
Hospital Affiliations
Oklahoma City VA Medical CenterOklahoma City, Oklahoma
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
